Concepedia

Jeffrey G. Supko

JG

Statistics

Publications

141

Citations

22.1K

H-Index

52

Active since

1990

Affiliations

Massachusetts General Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

National Cancer Institute

Brigham and Women's Hospital

Jeffrey G. Supko is an author at Massachusetts General Hospital specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

1990–2022

141

Publications

141

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al. · New England Journal of Medicine · 2004 · 11.5K citations

, , +16

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

Myrna R. Rosenfeld, Xiaobu Ye, Jeffrey G. Supko et al. · Autophagy · 2014 · 528 citations · Full text

, , +17

Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.

Rocio García‐Carbonero, Jeffrey G. Supko · PubMed · 2002 · 496 citations

, , +16

Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent

Jeffrey G. Supko, Robert L. Hickman, Michael R. Grever et al. · Cancer Chemotherapy and Pharmacology · 1995 · 496 citations

, , +9

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

Ultan McDermott, Sreenath V. Sharma, Lori Dowell et al. · Proceedings of the National Academy of Sciences · 2007 · 358 citations · Full text

, , +17

1–5 of 141